Cano Health, Inc. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported revenue was USD 788.07 million compared to USD 665.03 million a year ago. Net loss was USD 260.49 million compared to USD 54.23 million a year ago. Basic loss per share from continuing operations was USD 91.87 compared to USD 23.34 a year ago. Diluted loss per share from continuing operations was USD 91.87 compared to USD 23.34 a year ago.
For the nine months, revenue was USD 2,421.73 million compared to USD 2,058.54 million a year ago. Net loss was USD 429.39 million compared to USD 58.9 million a year ago. Basic loss per share from continuing operations was USD 161.33 compared to USD 27.86 a year ago. Diluted loss per share from continuing operations was USD 161.33 compared to USD 27.86 a year ago.